+1 (704) 266-3234

Global Human Milk Oligosaccharides (HMO) Market Size, Manufacturers, Supply Chain, Sales Channel And Clients, 2021-2027

Published on: Aug 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 116

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycanÕs that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Global Human Milk Oligosaccharides (HMO) key players include Abbott, Inbiose, Elicityl SA, Jennewein Biotechnologie, ZuChem, etc. North America is the largest consumption market, with a share about 65%, followed by Europe, with a share about 30 percent. In terms of product, 2'-FL & 3-FL is the largest segment, with a share about 70%. And in terms of application, the largest application is Infant Formula, followed by Functional Food & Beverages, and Food/Medical Supplements.

Market Analysis and Insights: Global Human Milk Oligosaccharides (HMO) Market
In 2020, the global Human Milk Oligosaccharides (HMO) market size was US$ 385 million and it is expected to reach US$ 2535.6 million by the end of 2027, with a CAGR of 30.6% during 2021-2027.
Global Human Milk Oligosaccharides (HMO) Scope and Market Size
Human Milk Oligosaccharides (HMO) market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Human Milk Oligosaccharides (HMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Human Milk Oligosaccharides (HMO) market is segmented into
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
The segment of 2'-FL & 3-FL holds a comparatively larger share in global market, which accounts for about 70%.

Segment by Application, the Human Milk Oligosaccharides (HMO) market is segmented into
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Other
The baby formula holds an important share in terms of applications, and accounts for 70% of the market share.

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape and Human Milk Oligosaccharides (HMO) Market Share Analysis
Human Milk Oligosaccharides (HMO) market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Human Milk Oligosaccharides (HMO) product introduction, recent developments, Human Milk Oligosaccharides (HMO) sales by region, type, application and by sales channel.

The major companies include:
Abbott
Inbiose
Elicityl SA
Jennewein Biotechnologie
ZuChem
Dextra Laboratories
Glycom

1 Study Coverage
1.1 Human Milk Oligosaccharides (HMO) Product Introduction
1.2 Market by Type
1.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type
1.2.2 2'-FL & 3-FL
1.2.3 Sialyllactose
1.2.4 LNT & LNnT
1.3 Market by Application
1.3.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application
1.3.2 Infant Formula
1.3.3 Functional Food & Beverages
1.3.4 Food/Medical Supplements
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts
2.1.1 Global Human Milk Oligosaccharides (HMO) Revenue 2016-2027
2.1.2 Global Human Milk Oligosaccharides (HMO) Sales 2016-2027
2.2 Human Milk Oligosaccharides (HMO) Market Size by Region: 2021 Versus 2027
2.3 Human Milk Oligosaccharides (HMO) Sales by Region (2016-2027)
2.3.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2016-2021
2.3.2 Global Human Milk Oligosaccharides (HMO) Sales Forecast by Region (2022-2027)
2.3.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2016-2027)
2.4 Human Milk Oligosaccharides (HMO) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2016-2021
2.4.2 Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Region (2022-2027)
2.4.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2016-2027)

3 Global Human Milk Oligosaccharides (HMO) by Manufacturers
3.1 Global Top Human Milk Oligosaccharides (HMO) Manufacturers by Sales
3.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturer (2016-2021)
3.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Human Milk Oligosaccharides (HMO) Manufacturers by Revenue
3.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturer (2016-2021)
3.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturer (2016-2021)
3.3 Global Human Milk Oligosaccharides (HMO) Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Human Milk Oligosaccharides (HMO) Manufacturers Covered: Ranking by Revenue
3.4.2 Global Human Milk Oligosaccharides (HMO) Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution, Product Type
3.5.1 Human Milk Oligosaccharides (HMO) Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Human Milk Oligosaccharides (HMO) Product Type
3.5.3 Date of International Manufacturers Enter into Human Milk Oligosaccharides (HMO) Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles
4.1 Abbott
4.1.1 Abbott Corporation Information
4.1.2 Abbott Description, Business Overview
4.1.3 Abbott Human Milk Oligosaccharides (HMO) Products Offered
4.1.4 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Abbott Human Milk Oligosaccharides (HMO) Revenue by Product
4.1.6 Abbott Human Milk Oligosaccharides (HMO) Revenue by Application
4.1.7 Abbott Human Milk Oligosaccharides (HMO) Revenue by Geographic Area
4.1.8 Abbott Human Milk Oligosaccharides (HMO) Revenue by Sales Channel
4.1.9 Abbott Recent Development
4.2 Inbiose
4.2.1 Inbiose Corporation Information
4.2.2 Inbiose Description, Business Overview
4.2.3 Inbiose Human Milk Oligosaccharides (HMO) Products Offered
4.2.4 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Inbiose Human Milk Oligosaccharides (HMO) Revenue by Product
4.2.6 Inbiose Human Milk Oligosaccharides (HMO) Revenue by Application
4.2.7 Inbiose Human Milk Oligosaccharides (HMO) Revenue by Geographic Area
4.2.8 Inbiose Human Milk Oligosaccharides (HMO) Revenue by Sales Channel
4.2.9 Inbiose Recent Development
4.3 Elicityl SA
4.3.1 Elicityl SA Corporation Information
4.3.2 Elicityl SA Description, Business Overview
4.3.3 Elicityl SA Human Milk Oligosaccharides (HMO) Products Offered
4.3.4 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Elicityl SA Human Milk Oligosaccharides (HMO) Revenue by Product
4.3.6 Elicityl SA Human Milk Oligosaccharides (HMO) Revenue by Application
4.3.7 Elicityl SA Human Milk Oligosaccharides (HMO) Revenue by Geographic Area
4.3.8 Elicityl SA Human Milk Oligosaccharides (HMO) Revenue by Sales Channel
4.3.9 Elicityl SA Recent Development
4.4 Jennewein Biotechnologie
4.4.1 Jennewein Biotechnologie Corporation Information
4.4.2 Jennewein Biotechnologie Description, Business Overview
4.4.3 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Products Offered
4.4.4 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Revenue by Product
4.4.6 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Revenue by Application
4.4.7 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Revenue by Geographic Area
4.4.8 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Revenue by Sales Channel
4.4.9 Jennewein Biotechnologie Recent Development
4.5 ZuChem
4.5.1 ZuChem Corporation Information
4.5.2 ZuChem Description, Business Overview
4.5.3 ZuChem Human Milk Oligosaccharides (HMO) Products Offered
4.5.4 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
4.5.5 ZuChem Human Milk Oligosaccharides (HMO) Revenue by Product
4.5.6 ZuChem Human Milk Oligosaccharides (HMO) Revenue by Application
4.5.7 ZuChem Human Milk Oligosaccharides (HMO) Revenue by Geographic Area
4.5.8 ZuChem Human Milk Oligosaccharides (HMO) Revenue by Sales Channel
4.5.9 ZuChem Recent Development
4.6 Dextra Laboratories
4.6.1 Dextra Laboratories Corporation Information
4.6.2 Dextra Laboratories Description, Business Overview
4.6.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Products Offered
4.6.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Dextra Laboratories Human Milk Oligosaccharides (HMO) Revenue by Product
4.6.6 Dextra Laboratories Human Milk Oligosaccharides (HMO) Revenue by Application
4.6.7 Dextra Laboratories Human Milk Oligosaccharides (HMO) Revenue by Geographic Area
4.6.8 Dextra Laboratories Recent Development
4.7 Glycom
4.7.1 Glycom Corporation Information
4.7.2 Glycom Description, Business Overview
4.7.3 Glycom Human Milk Oligosaccharides (HMO) Products Offered
4.7.4 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Glycom Human Milk Oligosaccharides (HMO) Revenue by Product
4.7.6 Glycom Human Milk Oligosaccharides (HMO) Revenue by Application
4.7.7 Glycom Human Milk Oligosaccharides (HMO) Revenue by Geographic Area
4.7.8 Glycom Recent Development

5 Breakdown Data by Type
5.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2016-2027)
5.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2016-2021)
5.1.2 Global Human Milk Oligosaccharides (HMO) Sales Forecast by Type (2022-2027)
5.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2016-2027)
5.2 Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Type (2016-2027)
5.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2016-2021)
5.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Type (2022-2027)
5.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2016-2027)
5.3 Human Milk Oligosaccharides (HMO) Average Selling Price (ASP) by Type (2016-2027)

6 Breakdown Data by Application
6.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2016-2027)
6.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2016-2021)
6.1.2 Global Human Milk Oligosaccharides (HMO) Sales Forecast by Application (2022-2027)
6.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2016-2027)
6.2 Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Application (2016-2027)
6.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2016-2021)
6.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Application (2022-2027)
6.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2016-2027)
6.3 Human Milk Oligosaccharides (HMO) Average Selling Price (ASP) by Application (2016-2027)

7 North America
7.1 North America Human Milk Oligosaccharides (HMO) Market Size YoY Growth 2016-2027
7.2 North America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
7.2.1 North America Human Milk Oligosaccharides (HMO) Sales by Country (2016-2027)
7.2.2 North America Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2027)
7.3 North America Human Milk Oligosaccharides (HMO) Sales by Type
7.4 North America Human Milk Oligosaccharides (HMO) Sales by Application

8 Asia-Pacific
8.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Facts & Figures by Region
8.2.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2016-2027)
8.2.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue by Region (2016-2027)
8.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Type
8.4 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Application

9 Europe
9.1 Europe Human Milk Oligosaccharides (HMO) Market Size YoY Growth 2016-2027
9.2 Europe Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
9.2.1 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2016-2027)
9.2.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2027)
9.3 Europe Human Milk Oligosaccharides (HMO) Sales by Type
9.4 Europe Human Milk Oligosaccharides (HMO) Sales by Application

10 Latin America
10.1 Latin America Human Milk Oligosaccharides (HMO) Market Size YoY Growth 2016-2027
10.2 Latin America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
10.2.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2016-2027)
10.2.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2027)
10.3 Latin America Human Milk Oligosaccharides (HMO) Sales by Type
10.4 Latin America Human Milk Oligosaccharides (HMO) Sales by Application

11 Middle East and Africa
11.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2016-2027)
11.2.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2027)
11.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Type
11.4 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Application

12 Supply Chain and Sales Channel Analysis
12.1 Human Milk Oligosaccharides (HMO) Supply Chain Analysis
12.2 Human Milk Oligosaccharides (HMO) Key Raw Materials and Upstream Suppliers
12.3 Human Milk Oligosaccharides (HMO) Clients Analysis
12.4 Human Milk Oligosaccharides (HMO) Sales Channel and Sales Model Analysis
12.4.1 Human Milk Oligosaccharides (HMO) Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Human Milk Oligosaccharides (HMO) Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Human Milk Oligosaccharides (HMO) Distributors

13 Market Dynamics
13.1 Human Milk Oligosaccharides (HMO) Market Drivers
13.2 Human Milk Oligosaccharides (HMO) Market Opportunities
13.3 Human Milk Oligosaccharides (HMO) Market Challenges
13.4 Human Milk Oligosaccharides (HMO) Market Restraints
13.5 PorterÕs Five Forces Analysis

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of 2'-FL & 3-FL
Table 3. Major Manufacturers of Sialyllactose
Table 4. Major Manufacturers of LNT & LNnT
Table 5. Global Human Milk Oligosaccharides (HMO) Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 6. Global Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2021 VS 2027
Table 7. Global Human Milk Oligosaccharides (HMO) Sales by Region (2016-2021) & (Kg)
Table 8. Global Human Milk Oligosaccharides (HMO) Sales Forecast by Region (2022-2027) & (Kg)
Table 9. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2016-2021) & (US$ Million)
Table 10. Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 11. Global Human Milk Oligosaccharides (HMO) Sales by Manufacturer (2016-2021) & (Kg)
Table 12. Global Human Milk Oligosaccharides (HMO) Sales Share by Manufacturer (2016-2021)
Table 13. Human Milk Oligosaccharides (HMO) Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 14. Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturer (2016-2021)
Table 15. Key Manufacturers Human Milk Oligosaccharides (HMO) Price (2016-2021) & (USD/Kg)
Table 16. Ranking of Global Top Human Milk Oligosaccharides (HMO) Manufacturers by Revenue (US$ Million) in 2020
Table 17. Global Human Milk Oligosaccharides (HMO) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 18. Global Human Milk Oligosaccharides (HMO) by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Milk Oligosaccharides (HMO) as of 2020)
Table 19. Human Milk Oligosaccharides (HMO) Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Human Milk Oligosaccharides (HMO) Product Type
Table 21. Date of International Manufacturers Enter into Human Milk Oligosaccharides (HMO) Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Abbott Corporation Information
Table 24. Abbott Description and Business Overview
Table 25. Abbott Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 26. Abbott Human Milk Oligosaccharides (HMO) Product
Table 27. Abbott Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Product
Table 28. Abbott Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Application
Table 29. Abbott Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Geographic Area
Table 30. Abbott Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Sales Channel
Table 31. Abbott Recent Development
Table 32. Inbiose Corporation Information
Table 33. Inbiose Description and Business Overview
Table 34. Inbiose Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 35. Inbiose Human Milk Oligosaccharides (HMO) Product
Table 36. Inbiose Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Product
Table 37. Inbiose Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Application
Table 38. Inbiose Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Geographic Area
Table 39. Inbiose Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Sales Channel
Table 40. Inbiose Recent Development
Table 41. Elicityl SA Corporation Information
Table 42. Elicityl SA Description and Business Overview
Table 43. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 44. Elicityl SA Human Milk Oligosaccharides (HMO) Product
Table 45. Elicityl SA Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Product
Table 46. Elicityl SA Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Application
Table 47. Elicityl SA Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Geographic Area
Table 48. Elicityl SA Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Sales Channel
Table 49. Elicityl SA Recent Development
Table 50. Jennewein Biotechnologie Corporation Information
Table 51. Jennewein Biotechnologie Description and Business Overview
Table 52. Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 53. Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Product
Table 54. Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Product
Table 55. Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Application
Table 56. Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Geographic Area
Table 57. Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Sales Channel
Table 58. Jennewein Biotechnologie Recent Development
Table 59. ZuChem Corporation Information
Table 60. ZuChem Description and Business Overview
Table 61. ZuChem Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 62. ZuChem Human Milk Oligosaccharides (HMO) Product
Table 63. ZuChem Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Product
Table 64. ZuChem Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Application
Table 65. ZuChem Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Geographic Area
Table 66. ZuChem Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Sales Channel
Table 67. ZuChem Recent Development
Table 68. Dextra Laboratories Corporation Information
Table 69. Dextra Laboratories Description and Business Overview
Table 70. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product
Table 72. Dextra Laboratories Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Product
Table 73. Dextra Laboratories Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Application
Table 74. Dextra Laboratories Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Geographic Area
Table 75. Dextra Laboratories Recent Development
Table 76. Glycom Corporation Information
Table 77. Glycom Description and Business Overview
Table 78. Glycom Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 79. Glycom Human Milk Oligosaccharides (HMO) Product
Table 80. Glycom Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Product
Table 81. Glycom Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Application
Table 82. Glycom Human Milk Oligosaccharides (HMO) Revenue (US$ Million) and Market Share by Geographic Area
Table 83. Glycom Recent Development
Table 84. Global Human Milk Oligosaccharides (HMO) Sales by Type (2016-2021) & (Kg)
Table 85. Global Human Milk Oligosaccharides (HMO) Sales Forecast by Type (2022-2027) & (Kg)
Table 86. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2016-2021) & (US$ Million)
Table 87. Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Human Milk Oligosaccharides (HMO) Sales by Application (2016-2021) & (Kg)
Table 89. Global Human Milk Oligosaccharides (HMO) Sales Forecast by Application (2022-2027) & (Kg)
Table 90. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2016-2021) & (US$ Million)
Table 91. Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. North America Human Milk Oligosaccharides (HMO) Sales by Country (2016-2021) & (Kg)
Table 93. North America Human Milk Oligosaccharides (HMO) Sales by Country (2022-2027) & (Kg)
Table 94. North America Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2021) & (US$ Million)
Table 95. North America Human Milk Oligosaccharides (HMO) Revenue by Country (2022-2027) & (US$ Million)
Table 96. North America Human Milk Oligosaccharides (HMO) Sales by Type (2016-2021) & (Kg)
Table 97. North America Human Milk Oligosaccharides (HMO) Sales by Application (2016-2021) & (Kg)
Table 98. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2016-2021) & (Kg)
Table 99. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2022-2027) & (Kg)
Table 100. Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue by Region (2016-2027) & (US$ Million)
Table 101. Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue by Region (2022-2027) & (US$ Million)
Table 102. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Type (2016-2021) & (Kg)
Table 103. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales by Application (2016-2021) & (Kg)
Table 104. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2016-2021) & (Kg)
Table 105. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2022-2027) & (Kg)
Table 106. Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2021) & (US$ Million)
Table 107. Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2022-2027) & (US$ Million)
Table 108. Europe Human Milk Oligosaccharides (HMO) Sales by Type (2016-2021) & (Kg)
Table 109. Europe Human Milk Oligosaccharides (HMO) Sales by Application (2016-2021) & (Kg)
Table 110. Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2016-2021) & (Kg)
Table 111. Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2022-2027) & (Kg)
Table 112. Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2021) & (US$ Million)
Table 113. Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2022-2027) & (US$ Million)
Table 114. Latin America Human Milk Oligosaccharides (HMO) Sales by Type (2016-2021) & (Kg)
Table 115. Latin America Human Milk Oligosaccharides (HMO) Sales by Application (2016-2021) & (Kg)
Table 116. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2016-2021) & (Kg)
Table 117. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2022-2027) & (Kg)
Table 118. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2021) & (US$ Million)
Table 119. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2022-2027) & (US$ Million)
Table 120. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Type (2016-2021) & (Kg)
Table 121. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Application (2016-2021) & (Kg)
Table 122. Human Milk Oligosaccharides (HMO) Key Raw Materials, Industry Status and Trend
Table 123. Human Milk Oligosaccharides (HMO) Key Raw Materials and Upstream Suppliers
Table 124. Human Milk Oligosaccharides (HMO) Clients Status and Trend
Table 125. Human Milk Oligosaccharides (HMO) Typical Clients
Table 126. Human Milk Oligosaccharides (HMO) Distributors
Table 127. Key Drivers: Impact Analysis (2022-2027)
Table 128. Human Milk Oligosaccharides (HMO) Market Drivers
Table 129. Human Milk Oligosaccharides (HMO) Market Opportunities
Table 130. Human Milk Oligosaccharides (HMO) Market Challenges
Table 131. Human Milk Oligosaccharides (HMO) Market Restraints
Table 132. Human Milk Oligosaccharides (HMO) PorterÕs Five Forces Analysis
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Milk Oligosaccharides (HMO) Product Picture
Figure 2. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type in 2021 & 2027
Figure 3. 2'-FL & 3-FL Product Picture
Figure 4. Sialyllactose Product Picture
Figure 5. LNT & LNnT Product Picture
Figure 6. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application in 2021 & 2027
Figure 7. Infant Formula Examples
Figure 8. Functional Food & Beverages Examples
Figure 9. Food/Medical Supplements Examples
Figure 10. Other Examples
Figure 11. Human Milk Oligosaccharides (HMO) Report Years Considered
Figure 12. Global Human Milk Oligosaccharides (HMO) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Human Milk Oligosaccharides (HMO) Market Size 2016-2027 (US$ Million)
Figure 14. Global Human Milk Oligosaccharides (HMO) Sales 2016-2027 (K Units)
Figure 15. Global Human Milk Oligosaccharides (HMO) Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Region (2016-2027)
Figure 17. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2016-2027)
Figure 18. Global Human Milk Oligosaccharides (HMO) Sales Share by Manufacturer in 2020
Figure 19. Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Type (2016-2027)
Figure 21. Global Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Type (2016-2027)
Figure 22. Human Milk Oligosaccharides (HMO) Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 23. Global Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Application (2016-2027)
Figure 24. Global Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Application (2016-2027)
Figure 25. Human Milk Oligosaccharides (HMO) Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 26. North America Human Milk Oligosaccharides (HMO) Revenue 2016-2027 (US$ Million)
Figure 27. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2016-2021)
Figure 28. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2016-2021)
Figure 29. Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue 2016-2027 (US$ Million)
Figure 30. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2016-2027)
Figure 31. Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2016-2027)
Figure 32. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2016-2021)
Figure 33. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2016-2021)
Figure 34. Europe Human Milk Oligosaccharides (HMO) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2016-2027)
Figure 36. Europe Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2016-2027)
Figure 37. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2016-2021)
Figure 38. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2016-2021)
Figure 39. Latin America Human Milk Oligosaccharides (HMO) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 40. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2016-2027)
Figure 41. Latin America Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2016-2021)
Figure 42. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2016-2021)
Figure 43. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2016-2021)
Figure 44. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 45. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2016-2027)
Figure 46. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2016-2027)
Figure 47. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2016-2021)
Figure 48. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2016-2021)
Figure 49. Human Milk Oligosaccharides (HMO) Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Human Milk Oligosaccharides (HMO) Raw Materials by Region in 2020
Figure 51. Human Milk Oligosaccharides (HMO) Distribution Channels
Figure 52. Global Human Milk Oligosaccharides (HMO) Percentage 2016-2027: Indirect Sales VS Direct Sales
Figure 53. Global Human Milk Oligosaccharides (HMO) Percentage 2016-2027: Online Sales VS Offline Sales
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.